Skip to main content
Top
Literature
2.
go back to reference B. Joob, V. Wiwanitkit, Viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin. Appl. Thromb. Hemost. 27, 10760296211020833 (2021)CrossRef B. Joob, V. Wiwanitkit, Viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin. Appl. Thromb. Hemost. 27, 10760296211020833 (2021)CrossRef
3.
go back to reference Y.L. Bussmann, M.L. Tillman, A.S. Pagliara, Neonatal thyrotoxicosis associated with the hyperviscosity syndrome. J. Pediatr. 90(2), 266–268 (1977)CrossRef Y.L. Bussmann, M.L. Tillman, A.S. Pagliara, Neonatal thyrotoxicosis associated with the hyperviscosity syndrome. J. Pediatr. 90(2), 266–268 (1977)CrossRef
4.
go back to reference C. Selby, Interference in immunoassay. Ann. Clin. Biochem. 36(Pt 6), 704–721 (1999)CrossRef C. Selby, Interference in immunoassay. Ann. Clin. Biochem. 36(Pt 6), 704–721 (1999)CrossRef
Metadata
Title
Thyrotoxicosis after COVID-19 vaccination
Authors
Rujittika Mungmunpuntipantip
Viroj Wiwanitkit
Publication date
01-01-2022
Publisher
Springer US
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02922-8

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue